es fr it za

Treating HIV Patients' Precancerous Growths Reduces Anal Cancer by Half

In a phase 3 trial, if HIV patients received treatment for precancerous HSILs, their risk for developing anal cancer was reduced by half.


View article...


Top stories of the last 30 days